• home
  • ONCOLOGY NGS TESTS

ONCOLOGY NGS TESTS

Do you want to know more about our oncology genetic diagnostic tests?
Fill in your data and you will receive by mail our FREE Clinical Oncology Genetic Catalog
Private Policy*

We will use your data to respond to inquiries and perform statistical analysis. For more information about processing and your rights, please see the privacy policy.

Marketing por

Solid Tumor Tests

Comprehensive Cancer Panel PLUS

Multi-biomaker NGS assay for solid tumors that evaluates >500 genes for SNVs, Indels, CNVs, LOH, Gene Fusions and also includes TMB and MSI. (FFPE samples)

Comprehensive Cancer Panel PLUS + HRD

This panel covers 46 genes of the HRR pathway and the Pan-Cancer Comprehensive Assay Plus provides clinically relevant information related to TMB, MSI, hotspot SNVs and Indels, CNVs and gene fusions, through the analysis of more than 500 genes.

Comprehensive Cancer Panel

Multi-biomaker NGS assay that covers 161 of the most clinically relevant cancer genes in solid tumors (FFPE samples)

Target Assay

Evaluate 52 genes of great relevance on multiple cancer types. Compatible with as little as 10 ng of genetic material extracted from FFPE tissue samples.

HRD on Ovarian Cancer

Evaluation of 46 genes of the homologous recombination repair pathway on solid tumors, detection of variants on genes of the HRR pathway that may cause HRD and Genomic Instability Metrics (GIM), gives information about genomic scarring/instability.

Colorectal Cancer (Lynch + FAP) 

Includes 19 relevant genes for colorectal cancer assessment including MMR (mismatch repair pathway) genes: MLH1, MSH2, MSH6 and PMS2

BRCA Test

Somatic and germline patogenic variants for BRCA1 and BRCA2 genes (FFPE + blood)

BRCA Extended Test

Analysis of 21 cancer genes including homologus repair pathway and MMR in FFPE biopsies
(Germline testing also available)

Lung Cancer Assay

Evaluates 12 genes with proven clinical utility in genetic material, extracted from paraffin-embedded tumor tissue (FFPE) samples

Hereditary Cancer Syndromes

Clarity Plus Test 

Analysis of more than 200 genes relevant in Hereditary Cancer Syndromes (germline mutations).

Clarity Test

Clarity Test is designed to screen 39 genes associated with hereditary cancer syndromes.

Liquid Biopsy Tests

Pan-Cancer Liquid Biopsy Using 1 single blood sample we evaluate 52 clinically relevant genes from cell-free DNA (cfDNA) and cell-free RNA (cfRNA) found in the plasma fraction of whole blood.
Colorectal Cancer Liquid Biopsy Using 1 single blood sample we assay 14 clinically relevant genes in colorectal cancer from cell-free DNA (cfDNA) found in the plasma fraction of whole blood.
Breast Cancer Liquid Biopsy Using 1 single blood sample we test 12 clinically relevant genes in breast cancer from cell-free DNA (cfDNA) found in the plasma fraction of whole blood.
Lung cancer liquid biopsy Using 1 single blood sample this test evaluates 12 clinically relevant genes in lung cancer from cell-free DNA (cfDNA) and cell-free RNA (cfRNA) found in the plasma fraction of whole blood.